ENST00000527963.1:n.*190-935G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000527963.1(NADSYN1):n.*190-935G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 152,126 control chromosomes in the GnomAD database, including 4,734 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.24 ( 4734 hom., cov: 33)
Consequence
NADSYN1
ENST00000527963.1 intron
ENST00000527963.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.328
Publications
41 publications found
Genes affected
NADSYN1 (HGNC:29832): (NAD synthetase 1) Nicotinamide adenine dinucleotide (NAD) is a coenzyme in metabolic redox reactions, a precursor for several cell signaling molecules, and a substrate for protein posttranslational modifications. NAD synthetase (EC 6.3.5.1) catalyzes the final step in the biosynthesis of NAD from nicotinic acid adenine dinucleotide (NaAD).[supplied by OMIM, Apr 2004]
NADSYN1 Gene-Disease associations (from GenCC):
- vertebral, cardiac, renal, and limb defects syndrome 3Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- congenital vertebral-cardiac-renal anomalies syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.322 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NADSYN1 | ENST00000527963.1 | n.*190-935G>A | intron_variant | Intron 3 of 3 | 4 | ENSP00000435570.1 |
Frequencies
GnomAD3 genomes AF: 0.236 AC: 35822AN: 152008Hom.: 4711 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
35822
AN:
152008
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.236 AC: 35876AN: 152126Hom.: 4734 Cov.: 33 AF XY: 0.246 AC XY: 18301AN XY: 74360 show subpopulations
GnomAD4 genome
AF:
AC:
35876
AN:
152126
Hom.:
Cov.:
33
AF XY:
AC XY:
18301
AN XY:
74360
show subpopulations
African (AFR)
AF:
AC:
13304
AN:
41484
American (AMR)
AF:
AC:
3993
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
498
AN:
3468
East Asian (EAS)
AF:
AC:
1646
AN:
5180
South Asian (SAS)
AF:
AC:
1614
AN:
4812
European-Finnish (FIN)
AF:
AC:
2984
AN:
10572
Middle Eastern (MID)
AF:
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10950
AN:
68000
Other (OTH)
AF:
AC:
552
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1360
2720
4080
5440
6800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1080
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.